Drug Enforcement D-0399-2025

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Status

Ongoing

Classification

Class II

Report Date

May 7, 2025

Termination Date

Product Information

Product description
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]
Product quantity
7,249 (cartons of 10 x 10 mL vials)
Reason for recall
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA

Location & Firm

Recalling firm
American Regent, Inc.
Address
6610 New Albany Rd E, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0399-2025
Event ID
96695
Recall initiation date
April 18, 2025
Center classification date
May 1, 2025
Code info
Lots, expiry: Lot 24086N0C0, 7/31/2025; Lot 24076N0C0, Lot 24090N0C0, 8/31/2025, Lot 25011N0C0, 6/30/2026;
More code info